We are live on
!
Find out more
A
AJOVista Portfolio holdings
AUM
$23.4M
1-Year Est. Return
76.18%
This Fund
S&P 500
This Quarter
Est. Return
+15.24%
1 Year Est. Return
+76.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$79.2M
AUM Growth
–
Cap. Flow
+$72.1M
Cap. Flow
% of AUM
90.95%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
455
New
455
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.21M |
| 2 |
Vipshop
VIPS
|
+$4.23M |
| 3 |
Manulife Financial
MFC
|
+$3.49M |
| 4 |
Scotiabank
BNS
|
+$3.28M |
| 5 |
Apple
AAPL
|
+$2.01M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.84% |
| 2 | Technology | 14.25% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Healthcare | 9.24% |
| 5 | Industrials | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Crexendo
CXDO
$223M
| $47.3K | 0.06% |
+9,759
| New | +$25.6K |
|
302
Turning Point Brands
TPB
$1.45B
| $46.9K | 0.06% |
+1,783
| New | +$40.8K |
|
303
Cogent Biosciences
COGT
$6.65B
| $44.7K | 0.06% |
+7,609
| New | +$58.3K |
|
304
Everspin Technologies
MRAM
$341M
| $43.3K | 0.05% |
+4,794
| New | +$44.4K |
|
305
Winmark
WINA
$1.2B
| $43K | 0.05% |
+103
| New | +$43.3K |
|
306
Northeast Community Bancorp
NECB
$368M
| $43K | 0.05% |
+2,422
| New | +$39.3K |
|
307
ARS Pharmaceuticals
SPRY
$509M
| $42.9K | 0.05% |
+7,822
| New | +$34.3K |
|
|
CBAY
308
DELISTED
Cymabay Therapeutics
CBAY
| $42.4K | 0.05% |
+1,794
| New | +$31.9K |
|
|
ETNB
309
DELISTED
89bio
ETNB
| $42.3K | 0.05% |
+3,789
| New | +$34.8K |
|
310
Rhythm Pharmaceuticals
RYTM
$6.81B
| $42.3K | 0.05% |
+920
| New | +$29K |
|
311
Stoneridge
SRI
$195M
| $42K | 0.05% |
+2,148
| New | +$37.3K |
|
312
Viemed Healthcare
VMD
$447M
| $42K | 0.05% |
+5,351
| New | +$38.8K |
|
313
Ethan Allen Interiors
ETD
$570M
| $40.5K | 0.05% |
+1,270
| New | +$36.4K |
|
314
Mirum Pharmaceuticals
MIRM
$6.46B
| $40.3K | 0.05% |
+1,364
| New | +$41.3K |
|
315
Uranium Energy
UEC
$4.75B
| $40.1K | 0.05% |
+6,268
| New | +$37.4K |
|
316
Oric Pharmaceuticals
ORIC
$1.15B
| $40.1K | 0.05% |
+4,357
| New | +$31.5K |
|
317
Savara
SVRA
$1.12B
| $39.7K | 0.05% |
+8,452
| New | +$32.4K |
|
318
OraSure Technologies
OSUR
$279M
| $39.5K | 0.05% |
+4,811
| New | +$31.5K |
|
319
Voyager Therapeutics
VYGR
$183M
| $38.6K | 0.05% |
+4,573
| New | +$33.2K |
|
|
THRX
320
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $38.6K | 0.05% |
+9,520
| New | +$29K |
|
|
USAP
321
DELISTED
Universal Stainless & Alloy
USAP
| $38.3K | 0.05% |
+1,907
| New | +$28.8K |
|
322
Natural Gas Services Group
NGS
$472M
| $38.3K | 0.05% |
+2,381
| New | +$34.4K |
|
|
RDUS
323
DELISTED
Radius Recycling
RDUS
| $38.2K | 0.05% |
+1,267
| New | +$33.4K |
|
|
MCHB
324
Mechanics Bancorp
MCHB
$3.72B
| $38K | 0.05% |
+3,693
| New | +$25.5K |
|
325
Independent Bank Corp
IBCP
$787M
| $37.8K | 0.05% |
+1,454
| New | +$31K |
|
Similar funds
TM
CMG
SRCM
LC
KLM
OCM
PFG
ICP
AJOVista's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for AJOVista, which disclosed 455 positions worth $79.2M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is iShares MSCI Saudi Arabia ETF: 158,420 shares worth $6.71M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Technology and Consumer Discretionary.
- AJOVista's largest Q4 2023 buy was iShares MSCI Saudi Arabia ETF: 158,420 shares worth $6.71M.
- AJOVista's ten largest holdings make up 38% of its $79.2M portfolio in Q4 2023.
- AJOVista disclosed 455 positions in Q4 2023, its first 13F filing on record.
Based on AJOVista's 13F filing for Q4 2023, filed 6 Feb 2024.